ClinicalTrials.gg
Drug

Ranolazine clinical trials

Also written Ranexa.

studies test it
85
open now
3
in phase 3
17
first study started
2004

How each study uses Ranolazine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Ranolazine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 Jan 2006 · RANEXA · NDA 021526 (FDA, Drugs@FDA)
European Union
8 Jul 2008 · Ranexa (previously Latixa) · EMEA/H/C/000805 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ranolazine
76
Ranolazine 500 MG
2
Renexa
2

Brand

Ranexa
59

Development codes

GS-9668
1
CVT500
1

Studies by the year they started

85 studies that test it; most in 2012 (18)

Studies that test Ranolazine, by start year
YearStudies
20042
20073
20081
20093
20105
201113
201218
20139
201412
20153
20164
20172
20184
20191
20201
20221
20252
20261

By phase

A phase 1/2 study counts in both.

Phase 1
10
Phase 2
24
Phase 3
17
Phase 4
27
No phase
11

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 26 · Other 59

Gilead Sciences (18) · University of Roma La Sapienza (3) · University of Rochester (2) · University of California, San Diego (2) · Food and Drug Administration (FDA) (2) · North Florida Foundation for Research and Education (2) · Cedars-Sinai Medical Center (2) · University of Pennsylvania (2)

Often tested with

Tested in the same studies.

Verapamil (2) · Dofetilide (2) · Metformin (2) · Dronedarone (1) · Lopinavir-ritonavir drug combination (1) · Chloroquine (1) · Diltiazem (1) · Quinidine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Ranolazine.

Studies

Open first, then newest update. How each study uses Ranolazine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 85

See all 85 studies that test Ranolazine →

Codes

What other systems call Ranolazine · ClinicalTrials.gg INT006587

  • MeSH (NLM) D000069458RanolazineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) A6IEZ5M406RANOLAZINEConfirmed FDA, NLM, Wikidata
  • RxNorm 35829Confirmed FDA, Wikidata
  • Wikidata Q907104ranolazineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C66507RanolazineOne source FDA
  • DrugBank DB00243One source Wikidata

Also registered as ranolazine hydrochloride (UNII F71253DJUN).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.